Department of Urology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University, School of Medicine, 639 Zhizaoju Rd, Shanghai, 200011, People's Republic of China.
BMC Cancer. 2018 Apr 10;18(1):403. doi: 10.1186/s12885-018-4257-1.
Extramammary Paget disease (EMPD) is a rare malignant dermatosis with poorly defined outcomes. We investigated clinical characteristics of invasive EMPD at different anatomic sites and by subject demographics to determine prognostic factors for overall survival (OS).
All patient data were collected from the Surveillance, Epidemiology, and End Results (SEER) program, 1973-2013, of the U.S. National Cancer Institute. Patients with invasive EMPD of skin, vulva/labia, vagina, scrotum/penis, or other sites were included. After excluding patients with unknown radiation status, data of 2001 patients were analyzed. Primary endpoint was EMPD mortality by anatomic sites. Independent variables included patients' demographic data, concurrent malignancy (ie, non-EMPD related cancers), tumor size, distant metastasis, and surgery and/or radiation or not.
Multivariate regression analysis showed that mortality was significantly higher in patients with vaginal EMPD than in patients with vulvar/labial EMPD (adjusted hazard ratio [aHR] = 3.26, p < 0.001). Patients with distant metastasis had higher mortality than those without (aHR = 3.36, p < 0.001). Patients who received surgery had significantly lower mortality than those who did not receive surgery (aHR = 0.77, p = 0.030), and those treated with radiation had significantly higher mortality than those who did not receive radiation (aHR = 1.60, p = 0.002). Older age was associated with significantly increased mortality (aHR = 1.09, p < 0.001), and mortality was significantly higher in males than in females (aHR = 1.42, p = 0.008).
In conclusion, among EMPD patients, mortality is higher in patients with vaginal EMPD than in those with vulvar/labial EMPD and higher in those who are older, those with concurrent malignancy or distant metastasis. Mortality is also higher in males than in females. Surgery is a protective factor and radiation is a risk factor for OS. Greater understanding of EMPD clinical characteristics, and considering EMPD in differential diagnosis of chronic genital and perianal dermatoses may provide support for early EMPD diagnosis and definitive surgical treatment.
派杰氏病(EMPD)是一种罕见的恶性皮肤病,其结局定义不明确。我们研究了不同解剖部位和患者人群的侵袭性 EMPD 的临床特征,以确定总生存(OS)的预后因素。
所有患者数据均来自美国国立癌症研究所的监测、流行病学和最终结果(SEER)计划,时间为 1973 年至 2013 年。纳入患有皮肤、外阴/阴唇、阴道、阴囊/阴茎或其他部位侵袭性 EMPD 的患者。排除未知放疗情况的患者后,对 2001 例患者的数据进行了分析。主要终点为不同解剖部位的 EMPD 死亡率。 自变量包括患者的人口统计学数据、合并恶性肿瘤(即非 EMPD 相关癌症)、肿瘤大小、远处转移、手术和/或放疗情况。
多变量回归分析显示,阴道 EMPD 患者的死亡率明显高于外阴/阴唇 EMPD 患者(调整后的危险比[aHR] = 3.26,p < 0.001)。有远处转移的患者死亡率高于无远处转移的患者(aHR = 3.36,p < 0.001)。接受手术的患者死亡率明显低于未接受手术的患者(aHR = 0.77,p = 0.030),接受放疗的患者死亡率明显高于未接受放疗的患者(aHR = 1.60,p = 0.002)。年龄较大与死亡率显著增加相关(aHR = 1.09,p < 0.001),男性死亡率明显高于女性(aHR = 1.42,p = 0.008)。
总之,在 EMPD 患者中,阴道 EMPD 患者的死亡率高于外阴/阴唇 EMPD 患者,年龄较大、合并恶性肿瘤或远处转移的患者死亡率较高。男性死亡率也高于女性。手术是保护因素,放疗是 OS 的危险因素。更好地了解 EMPD 的临床特征,并在慢性生殖器和肛周皮肤病的鉴别诊断中考虑 EMPD,可能有助于早期 EMPD 诊断和明确的手术治疗。